SOLANA BEACH, Calif., July 10, 2023 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, and neurological conditions, today announced that Gregory D. Gorgas, President & Chief Executive Officer of Artelo Biosciences, will…Read More
Artelo Biosciences CEO to Participate in the Benzinga All Access Event on July 11
